Paul E. Bock - Publications

Affiliations: 
Pathology Vanderbilt University, Nashville, TN 
Area:
human blood coagulation and fibrinolysis and their roles in cardiovascular and infectious diseases
Website:
https://medicine.mc.vanderbilt.edu/person/paul-e-bock-phd

78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Maddur AA, Voehler M, Panizzi P, Meiler J, Bock PE, Verhamme IM. Mapping of the fibrinogen-binding site on the staphylocoagulase C-terminal repeat region. The Journal of Biological Chemistry. 101493. PMID 34915025 DOI: 10.1016/j.jbc.2021.101493  0.681
2020 Panizzi P, Krohn-Grimberghe M, Keliher E, Ye YX, Grune J, Frodermann V, Sun Y, Muse CG, Bushey K, Iwamoto Y, van Leent MMT, Meerwaldt A, Toner YC, Munitz J, Maier A, ... ... Bock PE, et al. Multimodal imaging of bacterial-host interface in mice and piglets with endocarditis. Science Translational Medicine. 12. PMID 33148623 DOI: 10.1126/scitranslmed.aay2104  0.719
2020 Maddur AA, Kroh HK, Aschenbrenner ME, Gibson BH, Panizzi P, Sheehan JH, Meiler J, Bock PE, Verhamme IM. Specificity and affinity of the N-terminal residues in staphylocoagulase in binding to prothrombin. The Journal of Biological Chemistry. PMID 32156702 DOI: 10.1074/Jbc.Ra120.012588  0.814
2019 Huang X, Swanson R, Kroh HK, Bock PE. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function. The Journal of Biological Chemistry. PMID 30918026 DOI: 10.1074/jbc.RA118.006787  0.757
2018 Baaten CCFMJ, Swieringa F, Misztal T, Mastenbroek TG, Feijge MAH, Bock PE, Donners MMPC, Collins PW, Li R, van der Meijden PEJ, Heemskerk JWM. Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects. Blood Advances. 2: 2320-2331. PMID 30232085 DOI: 10.1182/Bloodadvances.2017011544  0.376
2016 Davis RW, Brannen AD, Hossain MJ, Monsma S, Bock PE, Nahrendorf M, Mead D, Lodes M, Liles MR, Panizzi P. Complete genome of Staphylococcus aureus Tager 104 provides evidence of its relation to modern systemic hospital-acquired strains. Bmc Genomics. 17: 179. PMID 26940863 DOI: 10.1186/S12864-016-2433-8  0.733
2015 Verhamme IM, Panizzi PR, Bock PE. Pathogen activators of plasminogen. Journal of Thrombosis and Haemostasis : Jth. 13: S106-14. PMID 26149011 DOI: 10.1111/Jth.12939  0.719
2015 Davis RW, Eggleston H, Johnson F, Nahrendorf M, Bock PE, Peterson T, Panizzi P. In Vivo Tracking of Streptococcal Infections of Subcutaneous Origin in a Murine Model. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 25921659 DOI: 10.1007/S11307-015-0856-2  0.694
2015 Micucci JA, Kamath P, Khan A, Bock PE, Krishnaswamy S. Long-Range Allosteric Linkage Between Exosites Reciprocally Regulates the Zymogenicity of Prothrombin Derivatives Blood. 126: 122-122. DOI: 10.1182/Blood.V126.23.122.122  0.474
2014 Verhamme IM, Bock PE. Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism. The Journal of Biological Chemistry. 289: 28006-18. PMID 25138220 DOI: 10.1074/Jbc.M114.589077  0.494
2013 Nolan M, Bouldin SD, Bock PE. Full time course kinetics of the streptokinase-plasminogen activation pathway. The Journal of Biological Chemistry. 288: 29482-93. PMID 23970549 DOI: 10.1074/Jbc.M113.477935  0.496
2012 Kroh HK, Bock PE. Effect of zymogen domains and active site occupation on activation of prothrombin by von Willebrand factor-binding protein. The Journal of Biological Chemistry. 287: 39149-57. PMID 23012355 DOI: 10.1074/Jbc.M112.415562  0.82
2011 Newell-Caito JL, Laha M, Tharp AC, Creamer JI, Xu H, Maddur AA, Tans G, Bock PE. Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes. The Journal of Biological Chemistry. 286: 38286-97. PMID 21911491 DOI: 10.1074/Jbc.M111.247122  0.512
2011 Panizzi P, Nahrendorf M, Figueiredo JL, Panizzi J, Marinelli B, Iwamoto Y, Keliher E, Maddur AA, Waterman P, Kroh HK, Leuschner F, Aikawa E, Swirski FK, Pittet MJ, Hackeng TM, ... ... Bock PE, et al. In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nature Medicine. 17: 1142-6. PMID 21857652 DOI: 10.1038/Nm.2423  0.775
2011 Laha M, Panizzi P, Nahrendorf M, Bock PE. Engineering streptokinase for generation of active site-labeled plasminogen analogs. Analytical Biochemistry. 415: 105-15. PMID 21570944 DOI: 10.1016/J.Ab.2011.04.025  0.71
2011 Corral-Rodríguez MÁ, Bock PE, Hernández-Carvajal E, Gutiérrez-Gallego R, Fuentes-Prior P. Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction. Blood. 117: 7164-73. PMID 21555742 DOI: 10.1182/Blood-2010-10-315309  0.464
2011 Kroh HK, Panizzi P, Tchaikovski S, Baird TR, Wei N, Krishnaswamy S, Tans G, Rosing J, Furie B, Furie BC, Bock PE. Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo. The Journal of Biological Chemistry. 286: 23345-56. PMID 21531712 DOI: 10.1074/Jbc.M111.230292  0.803
2010 Nicolaes GA, Bock PE, Segers K, Wildhagen KC, Dahlbäck B, Rosing J. Inhibition of thrombin formation by active site mutated (S360A) activated protein C. The Journal of Biological Chemistry. 285: 22890-900. PMID 20484050 DOI: 10.1074/Jbc.M110.131029  0.555
2010 Berny MA, Munnix IC, Auger JM, Schols SE, Cosemans JM, Panizzi P, Bock PE, Watson SP, McCarty OJ, Heemskerk JW. Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear. Plos One. 5: e10415. PMID 20454680 DOI: 10.1371/Journal.Pone.0010415  0.679
2010 Wiles KG, Panizzi P, Kroh HK, Bock PE. Skizzle is a novel plasminogen- and plasmin-binding protein from Streptococcus agalactiae that targets proteins of human fibrinolysis to promote plasmin generation. The Journal of Biological Chemistry. 285: 21153-64. PMID 20435890 DOI: 10.1074/Jbc.M110.107730  0.819
2009 Tharp AC, Laha M, Panizzi P, Thompson MW, Fuentes-Prior P, Bock PE. Plasminogen substrate recognition by the streptokinase-plasminogen catalytic complex is facilitated by Arg253, Lys256, and Lys257 in the streptokinase beta-domain and kringle 5 of the substrate. The Journal of Biological Chemistry. 284: 19511-21. PMID 19473980 DOI: 10.1074/Jbc.M109.005512  0.732
2009 Kroh HK, Panizzi P, Bock PE. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proceedings of the National Academy of Sciences of the United States of America. 106: 7786-91. PMID 19416890 DOI: 10.1073/Pnas.0811750106  0.832
2008 Verhamme IM, Bock PE. Rapid-reaction kinetic characterization of the pathway of streptokinase-plasmin catalytic complex formation. The Journal of Biological Chemistry. 283: 26137-47. PMID 18658146 DOI: 10.1074/Jbc.M804038200  0.461
2008 Smith SB, Verhamme IM, Sun MF, Bock PE, Gailani D. Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation. The Journal of Biological Chemistry. 283: 6696-705. PMID 18192270 DOI: 10.1074/Jbc.M707234200  0.398
2007 Segers K, Dahlbäck B, Bock PE, Tans G, Rosing J, Nicolaes GA. The role of thrombin exosites I and II in the activation of human coagulation factor V. The Journal of Biological Chemistry. 282: 33915-24. PMID 17878169 DOI: 10.1074/Jbc.M701123200  0.463
2007 Hacisalihoglu A, Panizzi P, Bock PE, Camire RM, Krishnaswamy S. Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase. The Journal of Biological Chemistry. 282: 32974-82. PMID 17848548 DOI: 10.1074/Jbc.M706529200  0.711
2007 Henry BL, Monien BH, Bock PE, Desai UR. A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids. The Journal of Biological Chemistry. 282: 31891-9. PMID 17804413 DOI: 10.1074/Jbc.M704257200  0.445
2007 Munnix IC, Kuijpers MJ, Auger J, Thomassen CM, Panizzi P, van Zandvoort MA, Rosing J, Bock PE, Watson SP, Heemskerk JW. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 2484-90. PMID 17761939 DOI: 10.1161/Atvbaha.107.151100  0.643
2007 Bock PE, Panizzi P, Verhamme IM. Exosites in the substrate specificity of blood coagulation reactions. Journal of Thrombosis and Haemostasis : Jth. 81-94. PMID 17635714 DOI: 10.1111/J.1538-7836.2007.02496.X  0.74
2007 Kroh HK, Tans G, Nicolaes GA, Rosing J, Bock PE. Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation. The Journal of Biological Chemistry. 282: 16095-104. PMID 17430903 DOI: 10.1074/Jbc.M610577200  0.785
2006 Panizzi P, Boxrud PD, Verhamme IM, Bock PE. Binding of the COOH-terminal lysine residue of streptokinase to plasmin(ogen) kringles enhances formation of the streptokinase.plasmin(ogen) catalytic complexes. The Journal of Biological Chemistry. 281: 26774-8. PMID 16857686 DOI: 10.1074/Jbc.C600171200  0.752
2006 Panizzi P, Friedrich R, Fuentes-Prior P, Kroh HK, Briggs J, Tans G, Bode W, Bock PE. Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions. The Journal of Biological Chemistry. 281: 1169-78. PMID 16230340 DOI: 10.1074/Jbc.M507955200  0.819
2006 Panizzi P, Friedrich R, Fuentes-Prior P, Richter K, Bock PE, Bode W. Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes. The Journal of Biological Chemistry. 281: 1179-87. PMID 16230339 DOI: 10.1074/Jbc.M507956200  0.744
2006 Friedrich R, Panizzi P, Kawabata S, Bode W, Bock PE, Fuentes-Prior P. Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation. The Journal of Biological Chemistry. 281: 1188-95. PMID 16230338 DOI: 10.1074/Jbc.M507957200  0.725
2006 Smith SB, Sun M, Bock PE, Gailani D. Independence of Factor XIa Subunits in Factor IX Activation. Blood. 108: 334-334. DOI: 10.1182/Blood.V108.11.334.334  0.528
2006 Panizzi PR, Bock PE. Identification and Characterization of a Sodium Ion Binding Site on the Staphylocoagulase-Prothrombin Complex. Blood. 108: 1700-1700. DOI: 10.1182/Blood.V108.11.1700.1700  0.727
2006 Creamer JI, Panizzi PR, Bock PE. Streptococcus pyogenes Fibronectin-Binding Protein Is a Novel Prothrombin Activator. Blood. 108: 1691-1691. DOI: 10.1182/Blood.V108.11.1691.1691  0.775
2006 Bock P, Panizzi P, Kroh H. ID: 334 von Willebrand Factor Binding Protein is a Novel Conformational Activator of Prothrombin that Functions Through a Substrate-assisted Molecular Sexuality Mechanism Journal of Thrombosis and Haemostasis. 4: 117-117. DOI: 10.1111/J.1538-7836.2006.00334.X  0.794
2005 Bianchini EP, Orcutt SJ, Panizzi P, Bock PE, Krishnaswamy S. Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase. Proceedings of the National Academy of Sciences of the United States of America. 102: 10099-104. PMID 16006504 DOI: 10.1073/Pnas.0504704102  0.694
2005 Ogawa T, Verhamme IM, Sun MF, Bock PE, Gailani D. Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX. The Journal of Biological Chemistry. 280: 23523-30. PMID 15829482 DOI: 10.1074/Jbc.M500894200  0.469
2005 Bean RR, Verhamme IM, Bock PE. Role of the streptokinase alpha-domain in the interactions of streptokinase with plasminogen and plasmin. The Journal of Biological Chemistry. 280: 7504-10. PMID 15623524 DOI: 10.1074/Jbc.M411637200  0.373
2004 Panizzi P, Friedrich R, Fuentes-Prior P, Bode W, Bock PE. The staphylocoagulase family of zymogen activator and adhesion proteins. Cellular and Molecular Life Sciences : Cmls. 61: 2793-8. PMID 15558209 DOI: 10.1007/S00018-004-4285-7  0.717
2004 Boxrud PD, Verhamme IM, Bock PE. Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase. The Journal of Biological Chemistry. 279: 36633-41. PMID 15215240 DOI: 10.1074/Jbc.M405264200  0.524
2004 Boxrud PD, Bock PE. Coupling of conformational and proteolytic activation in the kinetic mechanism of plasminogen activation by streptokinase. The Journal of Biological Chemistry. 279: 36642-9. PMID 15215239 DOI: 10.1074/Jbc.M405265200  0.47
2004 Verhamme IM, Bock PE, Jackson CM. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II. The Journal of Biological Chemistry. 279: 9785-95. PMID 14701814 DOI: 10.1074/Jbc.M313962200  0.423
2003 Friedrich R, Panizzi P, Fuentes-Prior P, Richter K, Verhamme I, Anderson PJ, Kawabata S, Huber R, Bode W, Bock PE. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature. 425: 535-9. PMID 14523451 DOI: 10.1038/Nature01962  0.758
2003 Anderson PJ, Bock PE. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin. The Journal of Biological Chemistry. 278: 44489-95. PMID 12939270 DOI: 10.1074/Jbc.M306916200  0.396
2003 Anderson PJ, Nesset A, Bock PE. Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin. The Journal of Biological Chemistry. 278: 44482-8. PMID 12939269 DOI: 10.1074/Jbc.M306917200  0.479
2003 Bedsted T, Swanson R, Chuang YJ, Bock PE, Björk I, Olson ST. Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites. Biochemistry. 42: 8143-52. PMID 12846563 DOI: 10.1021/Bi034363Y  0.419
2003 Flanagan JJ, Chen JC, Miao Y, Shao Y, Lin J, Bock PE, Johnson AE. Signal recognition particle binds to ribosome-bound signal sequences with fluorescence-detected subnanomolar affinity that does not diminish as the nascent chain lengthens. The Journal of Biological Chemistry. 278: 18628-37. PMID 12621052 DOI: 10.1074/Jbc.M300173200  0.334
2002 Verhamme IM, Olson ST, Tollefsen DM, Bock PE. Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II. The Journal of Biological Chemistry. 277: 6788-98. PMID 11724802 DOI: 10.1074/Jbc.M110257200  0.444
2001 Anderson PJ, Bock PE. Biotin Derivatives of d-Phe-Pro-Arg-CH2Cl for Active-Site-Specific Labeling of Thrombin and Other Serine Proteinases Analytical Biochemistry. 296: 254-261. PMID 11554721 DOI: 10.1006/Abio.2001.5302  0.43
2001 Monteiro RQ, Bock PE, Bianconi ML, Zingali RB. Characterization of bothrojaracin interaction with human prothrombin. Protein Science. 10: 1897-1904. PMID 11514680 DOI: 10.1110/Ps.09001  0.455
2001 Boxrud PD, Verhamme IMA, Fay WP, Bock PE. Streptokinase triggers conformational activation of plasminogen through specific interactions of the amino-terminal sequence and stabilizes the active zymogen conformation. Journal of Biological Chemistry. 276: 26084-26089. PMID 11369771 DOI: 10.1074/Jbc.M101966200  0.529
2001 Pekovich SR, Bock PE, Hoover RL. Thrombin–thrombomodulin activation of protein C facilitates the activation of progelatinase A Febs Letters. 494: 129-132. PMID 11297749 DOI: 10.1016/S0014-5793(01)02296-7  0.371
2000 Boxrud PD, Bock PE. Streptokinase Binds Preferentially to the Extended Conformation of Plasminogen through Lysine Binding Site and Catalytic Domain Interactions Biochemistry. 39: 13974-13981. PMID 11076540 DOI: 10.1021/Bi000594I  0.499
2000 Boxrud PD, Fay WP, Bock PE. Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen. Journal of Biological Chemistry. 275: 14579-14589. PMID 10799544 DOI: 10.1074/Jbc.275.19.14579  0.502
2000 Anderson PJ, Nesset A, Dharmawardana KR, Bock PE. Role of Proexosite I in Factor Va-dependent Substrate Interactions of Prothrombin Activation Journal of Biological Chemistry. 275: 16435-16442. PMID 10748008 DOI: 10.1074/Jbc.M001255200  0.437
2000 Anderson PJ, Nesset A, Dharmawardana KR, Bock PE. Characterization of Proexosite I on Prothrombin Journal of Biological Chemistry. 275: 16428-16434. PMID 10748007 DOI: 10.1074/Jbc.M001254200  0.45
1999 Dharmawardana KR, Olson ST, Bock PE. Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragments. Journal of Biological Chemistry. 274: 18635-18643. PMID 10373475 DOI: 10.1074/Jbc.274.26.18635  0.463
1998 Colwell NS, Blinder MA, Tsiang M, Gibbs CS, Bock PE, Tollefsen DM. Allosteric effects of a monoclonal antibody against thrombin exosite II Biochemistry. 37: 15057-15065. PMID 9790668 DOI: 10.1021/Bi980925F  0.381
1998 Dharmawardana KR, Bock PE. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases. Biochemistry. 37: 13143-13152. PMID 9748321 DOI: 10.1021/Bi9812165  0.471
1997 Bock PE, Olson ST, Björk I. Inactivation of Thrombin by Antithrombin Is Accompanied by Inactivation of Regulatory Exosite I Journal of Biological Chemistry. 272: 19837-19845. PMID 9242645 DOI: 10.1074/Jbc.272.32.19837  0.501
1997 Hogg PJ, Bock PE. Modulation of thrombin and heparin activities by fibrin. Thrombosis and Haemostasis. 77: 424-433. DOI: 10.1055/S-0038-1655982  0.374
1996 Hogg PJ, Jackson CM, Labanowski JK, Bock PE. Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen. The Journal of Biological Chemistry. 271: 26088-95. PMID 8824251 DOI: 10.1074/Jbc.271.42.26088  0.511
1996 Bock PE, Day DE, Verhamme IM, Bernardo MM, Olson ST, Shore JD. Analogs of human plasminogen that are labeled with fluorescence probes at the catalytic site of the zymogen. Preparation, characterization, and interaction with streptokinase. The Journal of Biological Chemistry. 271: 1072-80. PMID 8557633 DOI: 10.1074/Jbc.271.2.1072  0.443
1996 Olson ST, Bock PE, Kvassman J, Shore JD, Lawrence DA, Ginsburg D, Björk I. Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family. Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes. The Journal of Biological Chemistry. 270: 30007-17. PMID 8530403 DOI: 10.1074/Jbc.270.50.30007  0.466
1995 Olson ST, Stephens AW, Hirs CH, Bock PE, Björk I. Kinetic characterization of the proteinase binding defect in a reactive site variant of the serpin, antithrombin. Role of the P1' residue in transition-state stabilization of antithrombin-proteinase complex formation. The Journal of Biological Chemistry. 270: 9717-24. PMID 7730349 DOI: 10.1074/Jbc.270.17.9717  0.438
1993 Bock PE. Thioester peptide chloromethyl ketones: reagents for active site-selective labeling of serine proteinases with spectroscopic probes. Methods in Enzymology. 222: 478-503. PMID 8412811 DOI: 10.1016/0076-6879(93)22030-J  0.332
1991 Olson ST, Bock PE, Sheffer R. Quantitative evaluation of solution equilibrium binding interactions by affinity partitioning: application to specific and nonspecific protein-heparin interactions. Archives of Biochemistry and Biophysics. 286: 533-545. PMID 1897976 DOI: 10.1016/0003-9861(91)90076-U  0.374
1989 Bock PE, Craig PA, Olson ST, Singh P. Isolation of human blood coagulation α-factor Xa by soybean trypsin inhibitor-Sepharose chromatography and its active-site titration with fluorescein mono-p-guanidinobenzoate☆ Archives of Biochemistry and Biophysics. 273: 375-388. PMID 2774557 DOI: 10.1016/0003-9861(89)90496-7  0.38
1988 Bock PE. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl. Biochemistry. 27: 6633-6639. PMID 3219359 DOI: 10.1021/Bi00417A063  0.423
1987 Shore JD, Day DE, Bock PE, Olson ST. Acceleration of surface-dependent autocatalytic activation of blood coagulation factor XII by divalent metal ions. Biochemistry. 26: 2250-8. PMID 3113477 DOI: 10.1021/Bi00382A027  0.331
1980 Bock PE, Luscombe M, Marshall SE, Pepper DS, Holbrook JJ. The multiple complexes formed by the interaction of platelet factor 4 with heparin. The Biochemical Journal. 191: 769-76. PMID 7283972 DOI: 10.1042/Bj1910769  0.365
1978 Holbrook JJ, Lewis BA, Freyssinet JM, Bock PE, Shore JD. Factor XIII: a study using polarization of fluorescence of the activation of the enzyme by calcium and by substrate [proceedings]. Biochemical Society Transactions. 5: 1247-51. PMID 923904 DOI: 10.1042/Bst0051247A  0.33
1978 Bock PE, Frieden C. Another look at the cold lability of enzymes Trends in Biochemical Sciences. 3: 100-103. DOI: 10.1016/S0968-0004(78)80013-9  0.509
1975 Bock PE, Gilbert HR, Frieden C. Analysis of the cold lability behavior of rabbit muscle phosphofructokinase Biochemical and Biophysical Research Communications. 66: 564-569. PMID 241341 DOI: 10.1016/0006-291X(75)90547-1  0.552
1974 Bock PE, Frieden C. pH-induced cold lability of rabbit skeletal muscle phosphofructokinase Biochemistry. 13: 4191-4196. PMID 4277765 DOI: 10.1021/Bi00717A020  0.469
Show low-probability matches.